{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:37:22Z","timestamp":1791247042304,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1482,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jacc.2009.03.066","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T09:33:02Z","timestamp":1248859982000},"page":"505-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"title":["Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Nicola C.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Steeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Townend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.03.066_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.03.066_bib2","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2009.03.066_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/hrt.2007.137539","article-title":"Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction","volume":"94","author":"Edwards","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.03.066_bib4","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.03.066_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-148-1-200801010-00191","article-title":"Inhibitors of the renin angiotensin system: proven benefits, unproven safety","volume":"148","author":"Parfrey","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2009.03.066_bib6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1681\/ASN.2007101079","article-title":"The aggravating mechanisms of aldosterone on kidney fibrosis","volume":"19","author":"Remuzzi","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2009.03.066_bib7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib10","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacc.2009.03.066_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.03.066_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib13","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","article-title":"Impact of aortic stiffness on survival in end-stage renal disease","volume":"99","author":"Blacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib14","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2009.03.066_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2009.03.066_bib17","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"issue":"Pt 1","key":"10.1016\/j.jacc.2009.03.066_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1469-7793.2000.t01-1-00263.x","article-title":"The influence of heart rate on augmentation index and central arterial pressure in humans","volume":"525","author":"Wilkinson","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.jacc.2009.03.066_bib19","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00004872-199816121-00033","article-title":"Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis","volume":"16","author":"Wilkinson","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2009.03.066_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2009.03.066_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(98)00315-4","article-title":"Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome","volume":"82","author":"Groenink","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.03.066_bib22","series-title":"An Introduction to Medical Statistics","first-page":"334","article-title":"An Introduction to Medical Statistics","author":"Bland","year":"1996"},{"key":"10.1016\/j.jacc.2009.03.066_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.313.7048.41","article-title":"Measurement error and correlation coefficients","volume":"313","author":"Bland","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2009.03.066_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ki.5000047","article-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","volume":"69","author":"Briet","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2009.03.066_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ahj.2006.12.025","article-title":"Regional left ventricular function in individuals with mild to moderate renal insufficiency: the Multi-Ethnic Study of Atherosclerosis","volume":"153","author":"Nasir","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.03.066_bib26","series-title":"USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2007"},{"key":"10.1016\/j.jacc.2009.03.066_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1081\/CEH-200031982","article-title":"Arterial stiffness: pathophysiology and clinical impact","volume":"26","author":"London","year":"2004","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jacc.2009.03.066_bib28","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/hrt.2004.046805","article-title":"Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease","volume":"91","author":"Mottram","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2009.03.066_bib29","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1681\/ASN.2005101038","article-title":"Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease","volume":"17","author":"Kimoto","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2009.03.066_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.03.066_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.03.066_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","article-title":"Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review","volume":"51","author":"Bomback","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2009.03.066_bib35","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.03.066_bib36","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study","volume":"12","author":"London","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2009.03.066_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.33.5.1111","article-title":"Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients","volume":"33","author":"Blacher","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.HYP.0000159190.71253.c3","article-title":"Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients","volume":"45","author":"Pannier","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2009.03.066_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","article-title":"Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population","volume":"113","author":"Willum-Hansen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.03.066_bib41","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2009.03.066_bib42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1\u20137) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2009.03.066_bib43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709016465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709016465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:33:31Z","timestamp":1760013211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709016465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0735109709016465"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.03.066","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.03.064","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}